Medicover to evaluate a potential separate listing in India

If a listing takes place, the process is estimated to take 12-24 months. Updates on the evaluation will be provided in due course. If a listing takes place, the process is estimated to take 12-24 months. Updates on the evaluation will be provided in due course. For further information, please contact: Hanna Bjellquist, Head of Investor Relations+46 703 033 272 [email protected]  This information is information that Medicover AB (publ)] is obliged to make public...

If a listing takes place, the process is estimated to take 12-24 months. Updates on the evaluation will be provided in due course.

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations
+46 703 033 272
[email protected] 

This information is information that Medicover AB (publ)] is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 22.00 CET on 10 December 2024.

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2023, Medicover had revenue of €1,746 million and more than 45,000 employees. For more information, go to www.medicover.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/medicover/r/medicover-to-evaluate-a-potential-separate-listing-in-india,c4080502

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/medicover-to-evaluate-a-potential-separate-listing-in-india-302328186.html